These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 9989554

  • 1. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects.
    Leon AC, Keller MB, Warshaw MG, Mueller TI, Solomon DA, Coryell W, Endicott J.
    Am J Psychiatry; 1999 Feb; 156(2):195-201. PubMed ID: 9989554
    [Abstract] [Full Text] [Related]

  • 2. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.
    Schneeweiss S, Patrick AR, Solomon DH, Mehta J, Dormuth C, Miller M, Lee JC, Wang PS.
    Arch Gen Psychiatry; 2010 May; 67(5):497-506. PubMed ID: 20439831
    [Abstract] [Full Text] [Related]

  • 3. Antidepressants and the risk of suicidal behaviors.
    Jick H, Kaye JA, Jick SS.
    JAMA; 2004 Jul 21; 292(3):338-43. PubMed ID: 15265848
    [Abstract] [Full Text] [Related]

  • 4. The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders.
    Warshaw MG, Keller MB.
    J Clin Psychiatry; 1996 Apr 21; 57(4):158-66. PubMed ID: 8601551
    [Abstract] [Full Text] [Related]

  • 5. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S, Patrick AR, Solomon DH, Dormuth CR, Miller M, Mehta J, Lee JC, Wang PS.
    Pediatrics; 2010 May 21; 125(5):876-88. PubMed ID: 20385637
    [Abstract] [Full Text] [Related]

  • 6. Fluoxetine: new indication. Depression in children: too many uncertainties.
    Prescrire Int; 2008 Oct 21; 17(97):186-7. PubMed ID: 19534039
    [No Abstract] [Full Text] [Related]

  • 7. A depressed adolescent at high risk of suicidal behavior.
    Vitiello B, Pearson JL.
    Am J Psychiatry; 2008 Mar 21; 165(3):323-8; quiz 408. PubMed ID: 18316430
    [No Abstract] [Full Text] [Related]

  • 8. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort.
    Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J.
    Arch Gen Psychiatry; 2006 Dec 21; 63(12):1358-67. PubMed ID: 17146010
    [Abstract] [Full Text] [Related]

  • 9. Treating the substance-abusing suicidal patient.
    Cornelius JR, Salloum IM, Lynch K, Clark DB, Mann JJ.
    Ann N Y Acad Sci; 2001 Apr 21; 932():78-90; discussion 91-3. PubMed ID: 11411192
    [Abstract] [Full Text] [Related]

  • 10. Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: a prospective study.
    Oquendo MA, Kamali M, Ellis SP, Grunebaum MF, Malone KM, Brodsky BS, Sackeim HA, Mann JJ.
    Am J Psychiatry; 2002 Oct 21; 159(10):1746-51. PubMed ID: 12359682
    [Abstract] [Full Text] [Related]

  • 11. Suicide prevention and serotonergic drugs.
    Montgomery SA.
    Int Clin Psychopharmacol; 1993 Nov 21; 8 Suppl 2():83-5. PubMed ID: 8201249
    [Abstract] [Full Text] [Related]

  • 12. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S, Merry S, McKenzie J, Sindahl P, Proctor M.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD004851. PubMed ID: 17636776
    [Abstract] [Full Text] [Related]

  • 13. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
    Brent DA, Emslie GJ, Clarke GN, Asarnow J, Spirito A, Ritz L, Vitiello B, Iyengar S, Birmaher B, Ryan ND, Zelazny J, Onorato M, Kennard B, Mayes TL, Debar LL, McCracken JT, Strober M, Suddath R, Leonard H, Porta G, Keller MB.
    Am J Psychiatry; 2009 Apr 18; 166(4):418-26. PubMed ID: 19223438
    [Abstract] [Full Text] [Related]

  • 14. Fluoxetine and suicidal ideation.
    Ratan DA.
    J Clin Psychopharmacol; 1997 Feb 18; 17(1):61-2. PubMed ID: 9004066
    [No Abstract] [Full Text] [Related]

  • 15. Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications.
    Smith EG.
    J Affect Disord; 2009 Apr 18; 114(1-3):143-8. PubMed ID: 18692250
    [Abstract] [Full Text] [Related]

  • 16. A naturalistic study of suicidal adolescents treated with an SSRI: suicidal ideation and behavior during 3-month post-hospitalization period.
    Ghaziuddin N, Merchant C, Dopp R, King C.
    Asian J Psychiatr; 2014 Oct 18; 11():13-9. PubMed ID: 25453691
    [Abstract] [Full Text] [Related]

  • 17. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
    Emslie GJ, Prakash A, Zhang Q, Pangallo BA, Bangs ME, March JS.
    J Child Adolesc Psychopharmacol; 2014 May 18; 24(4):170-9. PubMed ID: 24815533
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.
    Tollefson GD, Fawcett J, Winokur G, Beasley CM, Potvin JH, Faries DE, Rampey AH, Sayler ME.
    Ann Clin Psychiatry; 1993 Dec 18; 5(4):209-24. PubMed ID: 8312978
    [Abstract] [Full Text] [Related]

  • 19. Antidepressants and risks of suicide and suicide attempts: a 27-year observational study.
    Leon AC, Solomon DA, Li C, Fiedorowicz JG, Coryell WH, Endicott J, Keller MB.
    J Clin Psychiatry; 2011 May 18; 72(5):580-6. PubMed ID: 21658345
    [Abstract] [Full Text] [Related]

  • 20. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
    Atkinson SD, Prakash A, Zhang Q, Pangallo BA, Bangs ME, Emslie GJ, March JS.
    J Child Adolesc Psychopharmacol; 2014 May 18; 24(4):180-9. PubMed ID: 24813026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.